Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Welsh

Showing results (71-80 of 328) with videos related to

Pageof 33
Sort By:
Heart (British Cardiac Society)|February 18, 2011
Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivationJennifer Logue, Heather M Murray, Paul Welsh, et al.
Atherosclerosis|August 5, 2017
Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes StudyAnna H Price, Christopher J Weir, Paul Welsh, et al.
European Heart Journal|April 17, 2010
Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-upDavid Preiss, Paul Welsh, Heather M Murray, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 23, 2023
Twenty-four-hour ambulatory, but not clinic blood pressure associates with leptin in young adults with overweight or obesity: The African-PREDICT studyElandi van Niekerk, Shani Botha-Le Roux, Catharina M C Mels, et al.
Atherosclerosis|August 1, 2017
Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetesS Goya Wannamethee, Paul Welsh, Olia Papacosta, et al.
Atherosclerosis|October 10, 2014
The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspectiveNaomi J Rankin, David Preiss, Paul Welsh, et al.
Plos One|September 14, 2012
Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetesInsa Feinkohl, Naveed Sattar, Paul Welsh, et al.
Stroke|October 25, 2011
The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic strokeWilliam Whiteley, Joanna Wardlaw, Martin Dennis, et al.
Annals of the Rheumatic Diseases|November 26, 2009
Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort studyMike J L Peters, Paul Welsh, Iain B McInnes, et al.
Journal of the American College of Cardiology|August 17, 2013
Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering armPeter S Sever, Neil R Poulter, Choon L Chang, et al.
Pageof 33

Showing results (71-80 of 328) with videos related to

Sort By:
Pageof 33
Heart (British Cardiac Society)|February 18, 2011
Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivationJennifer Logue, Heather M Murray, Paul Welsh, et al.
Atherosclerosis|August 5, 2017
Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes StudyAnna H Price, Christopher J Weir, Paul Welsh, et al.
European Heart Journal|April 17, 2010
Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-upDavid Preiss, Paul Welsh, Heather M Murray, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 23, 2023
Twenty-four-hour ambulatory, but not clinic blood pressure associates with leptin in young adults with overweight or obesity: The African-PREDICT studyElandi van Niekerk, Shani Botha-Le Roux, Catharina M C Mels, et al.
Atherosclerosis|August 1, 2017
Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetesS Goya Wannamethee, Paul Welsh, Olia Papacosta, et al.
Atherosclerosis|October 10, 2014
The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspectiveNaomi J Rankin, David Preiss, Paul Welsh, et al.
Plos One|September 14, 2012
Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetesInsa Feinkohl, Naveed Sattar, Paul Welsh, et al.
Stroke|October 25, 2011
The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic strokeWilliam Whiteley, Joanna Wardlaw, Martin Dennis, et al.
Annals of the Rheumatic Diseases|November 26, 2009
Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort studyMike J L Peters, Paul Welsh, Iain B McInnes, et al.
Journal of the American College of Cardiology|August 17, 2013
Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering armPeter S Sever, Neil R Poulter, Choon L Chang, et al.
Pageof 33